Terms: = Liver cancer AND CRTC1, Q6UUV9, 23373, ENSG00000105662, KIAA0616, TORC1, MECT1, WAMTP1, FLJ14027 AND Treatment
3 results:
1. C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
Zhang Y; Yan Q; Gong L; Xu H; Liu B; Fang X; Yu D; Li L; Wei T; Wang Y; Wong CN; Lyu Z; Tang Y; Sham PC; Guan XY
Oncogene; 2021 Feb; 40(6):1147-1161. PubMed ID: 33323975
[TBL] [Abstract] [Full Text] [Related]
2. mTOR Inhibitors in Advanced Biliary Tract cancers.
Wu CE; Chen MH; Yeh CN
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30682771
[TBL] [Abstract] [Full Text] [Related]
3. Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal cell carcinoma tumorgrafts.
Ingels A; Zhao H; Thong AE; Saar M; Valta MP; Nolley R; Santos J; Peehl DM
Int J Cancer; 2014 May; 134(10):2322-9. PubMed ID: 24243565
[TBL] [Abstract] [Full Text] [Related]
